ArticleJournal of inflammation research2026

Topical Remibrutinib Attenuates LL37-Induced Rosacea-Like Dermatitis by Inhibiting BTK Activation, NF-κB Signaling and Mast Cell Activation.

Wangchao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.